SLCAX
Price
$16.83
Change
+$0.25 (+1.51%)
Updated
Aug 22 closing price
Net Assets
658.41M
VTSMX
Price
$154.82
Change
+$2.59 (+1.70%)
Updated
Aug 22 closing price
Net Assets
1.91T
Interact to see
Advertisement

SLCAX vs VTSMX

Header iconSLCAX vs VTSMX Comparison
Open Charts SLCAX vs VTSMXBanner chart's image
SEI Large Cap A (SIIT)
Price$16.83
Change+$0.25 (+1.51%)
VolumeN/A
Net Assets658.41M
Vanguard Total Stock Mkt Idx I
Price$154.82
Change+$2.59 (+1.70%)
VolumeN/A
Net Assets1.91T
SLCAX vs VTSMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
SLCAX vs. VTSMX commentary
Aug 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLCAX is a Buy and VTSMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 1.91T vs. SLCAX (658M). SLCAX pays higher dividends than VTSMX: SLCAX (1.44) vs VTSMX (1.09). SLCAX was incepted earlier than VTSMX: SLCAX (29 years) vs VTSMX (33 years). SLCAX (0.47) is less costly to investors than VTSMX (0.14). VTSMX has a lower initial minimum investment than SLCAX: VTSMX (3000) vs SLCAX (100000). VTSMX annual gain was more profitable for investors over the last year : 14.24 vs. SLCAX (4.96). VTSMX return over 5 years is better than : 82.37 vs. SLCAX (16.69).
SLCAXVTSMXSLCAX / VTSMX
Total Expense Ratio0.180.14129%
Annual Report Gross Expense Ratio0.470.14336%
Fund Existence29 years33 years-
Gain YTD10.0028.010125%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets658M1.91T0%
Annual Yield % from dividends1.441.09132%
Returns for 1 year4.9614.2435%
Returns for 3 years16.6551.6132%
Returns for 5 years16.6982.3720%
Returns for 10 years-5.09234.83-2%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FFBC26.551.04
+4.08%
First Financial Bancorp
IBO0.60N/A
+0.76%
Impact BioMedical Inc.
PFX49.500.26
+0.52%
PhenixFIN Corp
RPRX36.320.01
+0.03%
Royalty Pharma plc
RAPP14.77-0.16
-1.07%
Rapport Therapeutics Inc.